サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1538445

副腎皮質ホルモンAPI市場レポート：2030年までの動向、予測、競合分析

Adrenocortical Hormone API Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日
発行
Lucintel
ページ情報
英文 150 Pages
納期
3営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

副腎皮質ホルモンAPI市場レポート：2030年までの動向、予測、競合分析
出版日: 2024年07月01日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

副腎皮質ホルモンAPIの動向と予測

世界の副腎皮質ホルモンAPI市場は、2024年から2030年にかけてCAGR 5.9％で成長すると予測されます。この市場の主な促進要因は、ホルモン補充療法の需要拡大と副腎不全疾患の有病率の上昇です。世界の副腎皮質ホルモンAPI市場の将来は、注射剤、経口剤、外用剤、吸入剤の各市場における機会によって有望視されています。

副腎皮質ホルモンAPI：セグメント別

本調査には、世界の副腎皮質ホルモンAPIのタイプ別、用途別、地域別の予測が含まれています。

副腎皮質ホルモンAPI市場の洞察

Lucintelの予測では、プレドニゾンシリーズが最も高い成長が見込まれます。

同市場では注射剤が最も高い成長が見込まれます。

北米が最も高い成長が見込まれます。

よくある質問

Q1.市場の成長予測は：

A1.世界の副腎皮質ホルモンAPI市場は、2024年から2030年にかけてCAGR 5.9％で成長すると予想されています。

Q2.市場の成長に影響を与える主な促進要因は：

A2.この市場の主な促進要因は、ホルモン補充療法の需要拡大と副腎不全疾患の有病率の上昇です。

Q3.市場の主要セグメントは：

A3.副腎皮質ホルモンAPI市場の将来は、注射剤、経口剤、外用剤、吸入剤の各市場における機会により有望です。

Q4.市場の主要企業は：

A4.主要な副腎皮質ホルモンAPI企業は以下の通り：

  • Pfizer CentreOne
  • EuroAPI
  • GlaxoSmithKline
  • Teva Pharmaceutical Industries
  • Hovione
  • Axplora
  • Steroid Spa
  • Avik Pharmaceutical
  • Anuh Pharma
  • Symbiotec Pharmalab

Q5.今後、最大となる市場セグメントは：

A5.Lucintelは、プレドニゾンシリーズが最も高い成長を遂げると予測しています。

Q6.市場において、今後5年間に最大になると予想される地域は：

A6.北米が最も高い成長が見込まれます。

Q7.レポートのカスタマイズは可能か：

A7.はい、Lucintelは追加費用なしで10％のカスタマイズを提供します。

目次

第1章 エグゼクティブサマリー

第2章 世界の副腎皮質ホルモンAPI市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界の副腎皮質ホルモンAPI市場の動向（2018～2023年）と予測（2024～2030年）
  • 世界の副腎皮質ホルモンAPI市場：タイプ別
    • プレドニゾンシリーズ
    • デキサメタゾンシリーズ
    • ベタメタゾンシリーズ
    • ヒドロコルチゾンシリーズ
    • その他
  • 世界の副腎皮質ホルモンAPI市場：用途別
    • 注射剤
    • 経口剤
    • 外用剤
    • 吸入剤

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の副腎皮質ホルモンAPIの世界市場
  • 北米の副腎皮質ホルモンAPI市場
  • 欧州の副腎皮質ホルモンAPI市場
  • アジア太平洋の副腎皮質ホルモンAPI市場
  • その他地域の副腎皮質ホルモンAPI市場

第5章 競合分析

  • 製品ポートフォリオ分析
  • 業務統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略分析

  • 成長機会分析
  • 世界の副腎皮質ホルモンAPI市場の新たな動向
  • 戦略分析
    • 新製品開発
    • 世界の副腎皮質ホルモンAPI市場の能力拡大
    • 世界の副腎皮質ホルモンAPI市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 主要企業の企業プロファイル

  • Pfizer CentreOne
  • EuroAPI
  • GlaxoSmithKline
  • Teva Pharmaceutical Industries
  • Hovione
  • Axplora
  • Steroid Spa
  • Avik Pharmaceutical
  • Anuh Pharma
  • Symbiotec Pharmalab
目次

Adrenocortical Hormone API Trends and Forecast

The future of the global adrenocortical hormone API market looks promising with opportunities in the injectable drug, oral drug, for external use drug, and inhalation drug markets. The global adrenocortical hormone API market is expected to grow with a CAGR of 5.9% from 2024 to 2030. The major drivers for this market are growing demand for hormonal replacement therapies and rising prevalence of adrenal insufficiency disorders.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Adrenocortical Hormone API by Segment

The study includes a forecast for the global adrenocortical hormone API by type, application, and region.

Adrenocortical Hormone API Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Prednisone Series
  • Dexamethasone Series
  • Betamethasone Series
  • Hydrocortisone Series
  • Others

Adrenocortical Hormone API Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Injectable Drug
  • Oral Drug
  • For External Use Drug
  • Inhalation Drug

Adrenocortical Hormone API Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Adrenocortical Hormone API Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies adrenocortical hormone API companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the adrenocortical hormone API companies profiled in this report include-

  • Pfizer CentreOne
  • EuroAPI
  • GlaxoSmithKline
  • Teva Pharmaceutical Industries
  • Hovione
  • Axplora
  • Steroid Spa
  • Avik Pharmaceutical
  • Anuh Pharma
  • Symbiotec Pharmalab

Adrenocortical Hormone API Market Insights

Lucintel forecasts that prednisone series is expected to witness the highest growth.

Within this market, injectable drug is expected to witness the highest growth.

North America is expected to witness the highest growth.

Features of the Global Adrenocortical Hormone API Market

Market Size Estimates: Adrenocortical hormone API market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Adrenocortical hormone API market size by type, application, and region in terms of value ($B).

Regional Analysis: Adrenocortical hormone API market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the adrenocortical hormone API market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the adrenocortical hormone API market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for adrenocortical hormone API market?

Answer: The global adrenocortical hormone API market is expected to grow with a CAGR of 5.9% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the adrenocortical hormone API market?

Answer: The major drivers for this market are growing demand for hormonal replacement therapies and rising prevalence of adrenal insufficiency disorders.

Q3. What are the major segments for adrenocortical hormone API market?

Answer: The future of the adrenocortical hormone API market looks promising with opportunities in the injectable drug, oral drug, for external use drug, and inhalation drug markets.

Q4. Who are the key adrenocortical hormone API market companies?

Answer: Some of the key adrenocortical hormone API companies are as follows:

  • Pfizer CentreOne
  • EuroAPI
  • GlaxoSmithKline
  • Teva Pharmaceutical Industries
  • Hovione
  • Axplora
  • Steroid Spa
  • Avik Pharmaceutical
  • Anuh Pharma
  • Symbiotec Pharmalab

Q5. Which adrenocortical hormone API market segment will be the largest in future?

Answer: Lucintel forecasts that prednisone series is expected to witness the highest growth.

Q6. In adrenocortical hormone API market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness the highest growth.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the adrenocortical hormone API market by type (prednisone series, dexamethasone series, betamethasone series, hydrocortisone series, and others), application (injectable drug, oral drug, for external use drug, and inhalation drug), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Adrenocortical Hormone API Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Adrenocortical Hormone API Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Adrenocortical Hormone API Market by Type
    • 3.3.1: Prednisone Series
    • 3.3.2: Dexamethasone Series
    • 3.3.3: Betamethasone Series
    • 3.3.4: Hydrocortisone Series
    • 3.3.5: Others
  • 3.4: Global Adrenocortical Hormone API Market by Application
    • 3.4.1: Injectable Drug
    • 3.4.2: Oral Drug
    • 3.4.3: For External Use Drug
    • 3.4.4: Inhalation Drug

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Adrenocortical Hormone API Market by Region
  • 4.2: North American Adrenocortical Hormone API Market
    • 4.2.1: North American Adrenocortical Hormone API Market by Type: Prednisone Series, Dexamethasone Series, Betamethasone Series, Hydrocortisone Series, and Others
    • 4.2.2: North American Adrenocortical Hormone API Market by Application: Injectable Drug, Oral Drug, For External Use Drug, and Inhalation Drug
  • 4.3: European Adrenocortical Hormone API Market
    • 4.3.1: European Adrenocortical Hormone API Market by Type: Prednisone Series, Dexamethasone Series, Betamethasone Series, Hydrocortisone Series, and Others
    • 4.3.2: European Adrenocortical Hormone API Market by Application: Injectable Drug, Oral Drug, For External Use Drug, and Inhalation Drug
  • 4.4: APAC Adrenocortical Hormone API Market
    • 4.4.1: APAC Adrenocortical Hormone API Market by Type: Prednisone Series, Dexamethasone Series, Betamethasone Series, Hydrocortisone Series, and Others
    • 4.4.2: APAC Adrenocortical Hormone API Market by Application: Injectable Drug, Oral Drug, For External Use Drug, and Inhalation Drug
  • 4.5: ROW Adrenocortical Hormone API Market
    • 4.5.1: ROW Adrenocortical Hormone API Market by Type: Prednisone Series, Dexamethasone Series, Betamethasone Series, Hydrocortisone Series, and Others
    • 4.5.2: ROW Adrenocortical Hormone API Market by Application: Injectable Drug, Oral Drug, For External Use Drug, and Inhalation Drug

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Adrenocortical Hormone API Market by Type
    • 6.1.2: Growth Opportunities for the Global Adrenocortical Hormone API Market by Application
    • 6.1.3: Growth Opportunities for the Global Adrenocortical Hormone API Market by Region
  • 6.2: Emerging Trends in the Global Adrenocortical Hormone API Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Adrenocortical Hormone API Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Adrenocortical Hormone API Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Pfizer CentreOne
  • 7.2: EuroAPI
  • 7.3: GlaxoSmithKline
  • 7.4: Teva Pharmaceutical Industries
  • 7.5: Hovione
  • 7.6: Axplora
  • 7.7: Steroid Spa
  • 7.8: Avik Pharmaceutical
  • 7.9: Anuh Pharma
  • 7.10: Symbiotec Pharmalab